Velocity Novasp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2023-08-29
Share capital
671,700.00 PLN
Registered address
ul. Towarowa 28, 00-839 Warszawa, Poland
Electronic delivery address
AE:PL-61108-78287-STSHW-35
Financials
Revenue history (in k)
Filing timeliness
2 of 2 financial statements were filed late (the longest delay 40 days for 2025).
- 202524/08/2026
- 202422/08/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 3.35mMedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -131.41kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 3.44mMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 2.50mMedianUSD 278.35kAverageUSD 8.47m
Industry
Authorized Representatives
Katarzyna Ewa Buczyńska – Attorney-in-fact (sole)
Gwilym Paul Evans – Management Board Member
Michael Jeffrey Zaranek – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Velocity Clinical Research, Inc. | 13,434 | $181,442.46 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-11-01.
37 1240 2412 1978 0011 3039 8269
96 1240 2412 1111 0011 3039 8168
53 1090 2590 0000 0001 4162 0692
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 4,905PLN 4,905 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 22, 2026 | Commercial Companies Code notice | |
| Oct 23, 2025 | Merger plan | |
| Dec 18, 2023 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Fluence Technologysp. z o.o. | $2,486,673.06 | fluence.pl | ||
| Oncotransfersp. z o.o. | $704,767.72 | oncotransfer.pib-nio.pl | ||
| Smart FluidS.A. | $681,963.98 | smartfluid.pl | ||
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-12-01 | Switch to PKD 2025 (6 PKD 2007 codes → 6 PKD 2025 codes) | |
| 2024-04-12 | Name change (Ko-Med Nova → Velocity Nova) | |
| 2024-02-16 | Address change (Ul. Senatorska 18a, 00-082, Warszawa → Ul. Towarowa 28, 00-839, Warszawa) | |
| 2023-12-01 | Share capital increase (5,000.00 PLN → 671,700.00 PLN) | |
| 2023-12-01 | Name change (Sesile → Ko-Med Nova) |
FAQ
The main business activity of Velocity Nova focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on August 29, 2023.
The headquarters is located at: ul. Towarowa 28, 00-839 Warszawa.
The share capital of the company is PLN 671,700 (approx. $181,442).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 3,345,952 in 2025, which is a decrease of 26.2% compared to 2024.
No, in 2025 the company reported a net loss of USD 131,413.
The largest operating cost category falls under external services. This category amounted to USD 1,952,752 in 2025, representing 57% of all operating expenses.
Last updated: 2026-10-07